Risk factors associated with quantitative evidence of lung emphysema and fibrosis in an HIV-infected cohort

Journal of Acquired Immune Deficiency Syndromes

Volumn 71, Issue 4, 2016, Pages 420-427

  Leader, Joseph K ^a   Crothers, Kristina ^b   Huang, Laurence ^c   King, Mark A ^d   Morris, Alison ^a   Thompson, Bruce W ^e   Flores, Sonia C ^f   Drummond, Michael B ^g   Rom, William N ^h   Diaz, Philip T ^d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e Clinical Trials & Surveys Corp   (United States)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Computed tomography; Emphysema; HIV; Lung; Pulmonary fibrosis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGE; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RACE; RISK ASSESSMENT; RISK FACTOR; SMOKING; VIRUS LOAD; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; DIAGNOSTIC IMAGING; HIV INFECTIONS; MULTICENTER STUDY; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; X-RAY COMPUTED TOMOGRAPHY;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84960462550     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000894     Document Type: Article

References (76)

1. Cohen BA, Pomeranz S, Rabinowitz JG, et al. Pulmonary complications of AIDS: radiologic features. AJR Am J Roentgenol. 1984;143:115-122.
2. Kuhlman JE, Fishman EK, Hruban RH, et al. Diseases of the chest in AIDS: CT diagnosis. Radiographics. 1989;9:827-857.
3. Murray JF, Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Part I. Am Rev Respir Dis. 1990; 141:1356-1372.
4. Murray JF, Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Part II. Am Rev Respir Dis. 1990; 141:1582-1598.
5. Braithwaite RS, Justice AC, Chang CC, et al. Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med. 2005;118:890-898.
6. Crum NF, Riffenburgh RH, Wegner S, et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr. 2006;41:194-200.
7. Lau B, Gange SJ, Moore RD. Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3. J Acquir Immune Defic Syndr. 2007;44:179-187.
8. Marin B, Thiebaut R, Bucher HC, et al. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy. AIDS. 2009;23:1743-1753.
9. Mocroft A, Brettle R, Kirk O, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16:1663-1671.
10. Sider L, Gabriel H, Curry DR, et al. Pattern recognition of the pulmonary manifestations of AIDS on CT scans. Radiographics. 1993;13:771-784; discussion 785-776.
11. McGuinness G, Scholes JV, Garay SM, et al. Cytomegalovirus pneumonitis: spectrum of parenchymal CT findings with pathologic correlation in 21 AIDS patients. Radiology. 1994;192:451-459.
12. McGuinness G, Gruden JF, Bhalla M, et al. AIDS-related airway disease. AJR Am J Roentgenol. 1997;168:67-77.
13. Logan PM, Finnegan MM. Pulmonary complications in AIDS: CT appearances. Clin Radiol. 1998;53:567-573.
14. Richards PJ, Armstrong P, Parkin JM, et al. Chest imaging in AIDS. Clin Radiol. 1998;53:554-566.
15. Kuhlman JE. Imaging pulmonary disease in AIDS: state of the art. Eur Radiol. 1999;9:395-408.
16. Padley SP, King LJ. Computed tomography of the thorax in HIV disease. Eur Radiol. 1999;9:1556-1569.
17. Marchiori E, Muller NL, Soares Souza A Jr, et al. Pulmonary disease in patients with AIDS: high-resolution CT and pathologic findings. AJR Am J Roentgenol. 2005;184:757-764.
18. Allen CM, Al-Jahdali HH, Irion KL, et al. Imaging lung manifestations of HIV/AIDS. Ann Thorac Med. 2010;5:201-216.
19. Lichtenberger JP III, Sharma A, Zachary KC, et al. What a differential a virus makes: a practical approach to thoracic imaging findings in the context of HIV infection-part 1, pulmonary findings. AJR Am J Roentgenol. 2012;198:1295-1304.
20. Lichtenberger JP III, Sharma A, Zachary KC, et al. What a differential a virus makes: a practical approach to thoracic imaging findings in the context of HIV infection-part 2, extrapulmonary findings, chronic lung disease, and immune reconstitution syndrome. AJR Am J Roentgenol. 2012;198:1305-1312.
21. Kuhlman JE, Knowles MC, Fishman EK, et al. Premature bullous pulmonary damage in AIDS: CT diagnosis. Radiology. 1989;173: 23-26.
22. Diaz PT, Clanton TL, Pacht ER. Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Ann Intern Med. 1992;116:124-128.
23. Guillemi SA, Staples CA, Hogg JC, et al. Unexpected lung lesions in high resolution computed tomography (HRCT) among patients with advanced HIV disease. Eur Respir J. 1996;9:33-36.
24. King MA, Neal DE, St John R, et al. Bronchial dilatation in patients with HIV infection: CT assessment and correlation with pulmonary function tests and findings at bronchoalveolar lavage. AJR Am J Roentgenol. 1997;168:1535-1540.
25. Diaz PT, King MA, Pacht ER, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med. 2000;132:369-372.
26. Diaz PT, Wewers MD, King M, et al. Regional differences in emphysema scores and BAL glutathione levels in HIV-infected individuals. Chest. 2004;126:1439-1442.
27. Gingo MR, He J, Wittman C, et al. Contributors to diffusion impairment in HIV-infected persons. Eur Respir J. 2014;43:195-203.
28. Gelman M, King MA, Neal DE, et al. Focal air trapping in patients with HIV infection: CT evaluation and correlation with pulmonary function test results. AJR Am J Roentgenol. 1999;172:1033-1038.
29. Traill ZC, Miller RF, Shaw PJ. CT appearances of intrathoracic Kaposi's sarcoma in patients with AIDS. Br J Radiol. 1996;69:1104-1107.
30. Moskovic E, Miller R, Pearson M. High resolution computed tomography of Pneumocystis carinii pneumonia in AIDS. Clin Radiol. 1990;42:239-243.
31. Cattamanchi A, Nahid P, Marras TK, et al. Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection. Chest. 2008;133:875-880.
32. Hartman TE, Primack SL, Muller NL, et al. Diagnosis of thoracic complications in AIDS: accuracy of CT. AJR Am J Roentgenol. 1994; 162:547-553.
33. Gruden JF, Huang L, Webb WR, et al. AIDS-related Kaposi sarcoma of the lung: radiographic findings and staging system with bronchoscopic correlation. Radiology. 1995;195:545-552.
34. McGuinness G, Scholes JV, Jagirdar JS, et al. Unusual lymphoprolifer-ative disorders in nine adults with HIV or AIDS: CT and pathologic findings. Radiology. 1995;197:59-65.
35. Staples CA, Kang EY, Wright JL, et al. Invasive pulmonary aspergillosis in AIDS: radiographic, CT, and pathologic findings. Radiology. 1995; 196:409-414.
36. Edinburgh KJ, Jasmer RM, Huang L, et al. Multiple pulmonary nodules in AIDS: usefulness of CT in distinguishing among potential causes. Radiology. 2000;214:427-432.
37. Jasmer RM, Edinburgh KJ, Thompson A, et al. Clinical and radiographic predictors of the etiology of pulmonary nodules in HIV-infected patients. Chest. 2000;117:1023-1030.
38. Gold JA, Rom WN, Harkin TJ. Significance of abnormal chest radiograph findings in patients with HIV-1 infection without respiratory symptoms. Chest. 2002;121:1472-1477.
39. Richards PJ, Riddell L, Reznek RH, et al. High resolution computed tomography in HIV patients with suspected Pneumocystis carinii pneumonia and a normal chest radiograph. Clin Radiol. 1996;51:689-693.
40. Hidalgo A, Falco V, Mauleon S, et al. Accuracy of high-resolution CT in distinguishing between Pneumocystis carinii pneumonia and non-Pneumocystis carinii pneumonia in AIDS patients. Eur Radiol. 2003; 13:1179-1184.
41. McGuinness G, Naidich DP, Garay S, et al. AIDS associated bronchi-ectasis: CT features. J Comput Assist Tomogr. 1993;17:260-266.
42. Crothers K, Huang L, Goulet JL, et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med. 2011;183:388-395.
43. Hull MW, Phillips P, Montaner JS. Changing global epidemiology of pulmonary manifestations of HIV/AIDS. Chest. 2008;134:1287-1298.
44. Madeddu G, Fois AG, Calia GM, et al. Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? Infection. 2013;41:347-353.
45. Shiels MS, Cole SR, Kirk GD, et al. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009;52:611-622.
46. Guaraldi G, Besutti G, Scaglioni R, et al. The burden of image based emphysema and bronchiolitis in HIV-infected individuals on antiretro-viral therapy. PLoS One. 2014;9:e109027.
47. Drummond MB, Kirk GD, Astemborski J, et al. Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax. 2012;67:309-314.
48. Attia EF, Akgun KM, Wongtrakool C, et al. Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4. Chest. 2014;146:1543-1553.
49. Sigel K, Wisnivesky J, Shahrir S, et al. Findings in asymptomatic HIV-infected patients undergoing chest computed tomography testing: implications for lung cancer screening. AIDS. 2014;28:1007-1014.
50. Busi Rizzi E, Schinina V, Palmieri F, et al. Radiological patterns in HIV-associated pulmonary tuberculosis: comparison between HAART-treated and non-HAART-treated patients. Clin Radiol. 2003;58: 469-473.
51. Marras TK, Morris A, Gonzalez LC, et al. Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus. Am J Respir Crit Care Med. 2004;170:793-798.
52. Samperiz G, Guerrero D, Lopez M, et al. Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapy. HIV Med. 2014;15:321-329.
53. Crothers K, Thompson BW, Burkhardt K, et al. HIV-associated lung infections and complications in the era of combination antiretroviral therapy. Proc Am Thorac Soc. 2011;8:275-281.
54. Crothers K, McGinnis K, Kleerup E, et al. HIV infection is associated with reduced pulmonary diffusing capacity. J Acquir Immune Defic Syndr. 2013;64:271-278.
55. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319-338.
56. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26:720-735.
57. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159:179-187.
58. Neas LM, Schwartz J. The determinants of pulmonary diffusing capacity in a national sample of U.S. adults. Am J Respir Crit Care Med. 1996; 153:656-664.
59. Leader JK, Zheng B, Rogers RM, et al. Automated lung segmentation in X-ray computed tomography: development and evaluation of a heuristic threshold-based scheme. Acad Radiol. 2003;10:1224-1236.
60. Muller NL, Staples CA, Miller RR, et al. "Density mask". An objective method to quantitate emphysema using computed tomography. Chest. 1988;94:782-787.
61. Gevenois PA, de Maertelaer V, De Vuyst P, et al. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med. 1995;152:653-657.
62. Wang Z, Gu S, Leader JK, et al. Optimal threshold in CT quantification of emphysema. Eur Radiol. 2013;23:975-984.
63. Lederer DJ, Enright PL, Kawut SM, et al. Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. Am J Respir Crit Care Med. 2009;180:407-414.
64. Washko GR, Hunninghake GM, Fernandez IE, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med. 2011;364:897-906.
65. Podolanczuk A, Sonti R, Kawut SM, et al. Cross-sectional associations of ICAM-1 and HDL with subclinical interstitial lung disease (ILD): the MESA Lung Fibrosis Study. Am J Respir Crit Care Med. 2014;189: A3928.
66. Duffy P, Wang X, Lin PH, et al. HIV Nef protein causes endothelial dysfunction in porcine pulmonary arteries and human pulmonary artery endothelial cells. J Surg Res. 2009;156:257-264.
67. Kline ER, Sutliff RL. The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction. J Investig Med. 2008;56:752-769.
68. Bankier AA, De Maertelaer V, Keyzer C, et al. Pulmonary emphysema: subjective visual grading versus objective quantification with macroscopic morphometry and thin-section CT densitometry. Radiology. 1999; 211:851-858.
69. Cavigli E, Camiciottoli G, Diciotti S, et al. Whole-lung densitometry versus visual assessment of emphysema. Eur Radiol. 2009;19: 1686-1692.
70. Cederlund K, Bergstrand L, Hogberg S, et al. Visual classification of emphysema heterogeneity compared with objective measurements: HRCT vs spiral CT in candidates for lung volume reduction surgery. Eur Radiol. 2002;12:1045-1051.
71. COPDGene CT Workshop Group, Barr RG, Berkowitz EA, et al. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD. 2012;9:151-159.
72. Hersh CP, Washko GR, Jacobson FL, et al. Interobserver variability in the determination of upper lobe-predominant emphysema. Chest. 2007; 131:424-431.
73. Mets OM, Smit EJ, Mohamed Hoesein FA, et al. Visual versus automated evaluation of chest computed tomography for the presence of chronic obstructive pulmonary disease. PLoS One. 2012;7:e42227.
74. Hersh CP, Make BJ, Lynch DA, et al. Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus. BMC Pulm Med. 2014;14:164.
75. Johannessen A, Skorge TD, Bottai M, et al. Mortality by level of emphysema and airway wall thickness. Am J Respir Crit Care Med. 2013;187:602-608.
76. Yahaba M, Kawata N, Iesato K, et al. The effects of emphysema on airway disease: correlations between multi-detector CT and pulmonary function tests in smokers. Eur J Radiol. 2014;83: 1022-1028.